Intracellular Delivery III Market Entry Barriers of Nanomedicines /
A critical review is attempted to assess the status of nanomedicine entry onto the market. The emergence of new potential therapeutic entities such as DNA and RNA fragments requires that these new "drugs" will need to be delivered in a cell-and organelle-specific manner. Although efforts h...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | |
Otros Autores: | , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Cham :
Springer International Publishing : Imprint: Springer,
2016.
|
Edición: | 1st ed. 2016. |
Colección: | Fundamental Biomedical Technologies,
|
Temas: | |
Acceso en línea: | Texto Completo |